Journal
BIOMARKERS IN MEDICINE
Volume 1, Issue 3, Pages 375-385Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/17520363.1.3.375
Keywords
alpha 1-antitrypsin; Alzheimer's disease; biomarker; cerebrospinal fluid; heme oxygenase-1; mild cognitive impairment; plasma
Categories
Ask authors/readers for more resources
The advent of an accessible chemical biological marker that differentiates early, sporadic Alzheimer's disease (AD) from normal aging and other dementing illnesses, and identifies individuals with mild cognitive impairment who are destined to deteriorate to Alzheimer's dementia, would represent a major achievement in the evaluation and management of this common neurodegenerative disorder. Although several candidate biomarkers of sporadic AD have been identified and commercialized, none currently fulfill the criteria for an ideal test. In this article, we review evidence implicating blood heme oxygenase-1 mRNA/protein levels and a recently identified plasma heme oxygenase-1 suppressor factor as potential biomarkers of AD and mild cognitive impairment.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available